Job Description
Title: Strategic Deal Partner (Biotech Hedge Funds) Compensation: 20–25% Uncapped Commission + Optional Advisory Equity Structure: Independent Contractor / Introducer Agreement Opportunity: Sell Risk Visibility, Not Software. floatz uses AI to stress-test the science behind biotech programs. Our platform surfaced major toxicity red flags in Rubius ~2 years before its $200M+ collapse. We’re expanding on the buy-side and seeking a Deal Partner to originate introductions into biotech-focused hedge funds. This is an access-driven role. Not volume sales. Who You Are You’re already connected to PMs or pod leads. Likely backgrounds: • Expert Networks (GLG/AlphaSights): Ready to monetize real influence. • Institutional / PB / Research Sales: Fluent in Soft Dollars (28e). • Cap Intro / HF Connector: Your intros get taken. You understand: • binary events • readout risk • drawdowns • scientific failure risk • pass-through expenses The Role • Your job: Book a 20-min “Risk Review” with a PM holding a biotech ticker. • Our job: Run the diligence, present risks, close the engagement. You focus on origination. Not long cycles. The Deal • Commission: 20–25% of the first engagement (uncapped). Most initial engagements fall in the $48.5k–$145k range, translating to $10k–$36k+ per introduction. • Equity: Optional micro-advisory equity for consistent high-impact originators • Engagements are short-cycle and fundable via Soft Dollars (28e) DO NOT APPLY IF... ⛔ You want a base salary ⛔ You’ve never sold to hedge funds ⛔ You struggle with high-level biotech or investment concepts ⛔ You rely on long, multi-touch SaaS sales sequences This is for people who can create trust-based access to decision-makers. Apply tot his job